Penile cancer: Clinical Practice Guidelines in Oncology

Autor: Pe, Clark, Pe, Spiess, Agarwal N, Mc, Biagioli, Ma, Eisenberger, Re, Greenberg, Hw, Herr, Brant Inman, Da, Kuban, Tm, Kuzel, Sm, Lele, Michalski J, Pagliaro L, Sk, Pal, Patterson A, Er, Plimack, Ks, Pohar, Mp, Porter, Jp, Richie, Wj, Sexton, Wu, Shipley, Ej, Small, Dl, Trump, Wile G, Tg, Wilson, Dwyer M, Ho M, National Comprehensive Cancer Network

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN, vol 11, iss 5
Europe PubMed Central

Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the United States and other developed countries. Although rare, it is associated with significant disfigurement, and only half of the patients survive beyo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::45f74b36421d90ce911e21a5393f1bde
https://escholarship.org/uc/item/53d840zs

The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.

Autor: Di Giorgio, Cristina¹ (AUTHOR), Bellini, Rachele¹ (AUTHOR), Lupia, Antonio^2,3 (AUTHOR), Massa, Carmen¹ (AUTHOR), Urbani, Ginevra¹ (AUTHOR), Bordoni, Martina¹ (AUTHOR), Marchianò, Silvia¹ (AUTHOR), Rosselli, Rosalinda⁴ (AUTHOR), De Gregorio, Rosa⁴ (AUTHOR), Rapacciuolo, Pasquale⁴ (AUTHOR), Sepe, Valentina⁴ (AUTHOR), Morretta, Elva⁵ (AUTHOR), Monti, Maria Chiara⁵ (AUTHOR), Moraca, Federica^3,4 (AUTHOR), Cari, Luigi¹ (AUTHOR), Ullah, Khan Rana Sami¹ (AUTHOR), Natalizi, Nicola⁶ (AUTHOR), Graziosi, Luigina⁶ (AUTHOR), Distrutti, Eleonora⁶ (AUTHOR), Biagioli, Michele¹ (AUTHOR)

Publikováno v: Cellular Oncology (2211-3428). Apr2024, Vol. 47 Issue 2, p695-710. 16p.

Emerging Trends: Neurofilament Biomarkers in Precision Neurology.

Autor: Sharma P; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, India., Giri A; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, India. aditigirimeerut@gmail.com., Tripathi PN; Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, India. tripathiprabhash@gmail.com.; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. tripathiprabhash@gmail.com.

Publikováno v: Neurochemical research [Neurochem Res] 2024 Dec; Vol. 49 (12), pp. 3208-3225. Date of Electronic Publication: 2024 Sep 30.

Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders.

Autor: Dobson H; Department of Psychiatry, Alfred Health, Melbourne, Victoria, Australia.; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Al Maawali S; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Malpas C; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia., Santillo AF; Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund/Malmö, Sweden., Kang M; Department of Psychiatry, Alfred Health, Melbourne, Victoria, Australia.; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Victoria, Australia., Todaro M; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Watson R; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Yassi N; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, China., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA., Foster E; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Neal A; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Velakoulis D; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Victoria, Australia., O'Brien TJ; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia., Eratne D; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Victoria, Australia., Kwan P; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.; Department of Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: Epilepsia [Epilepsia] 2024 Sep; Vol. 65 (9), pp. 2751-2763. Date of Electronic Publication: 2024 Jul 20.

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.

Autor: Di Giorgio, Cristina, Bellini, Rachele, Lupia, Antonio, Massa, Carmen, Bordoni, Martina, Marchianò, Silvia, Rosselli, Rosalinda, Sepe, Valentina, Rapacciuolo, Pasquale, Moraca, Federica, Morretta, Elva, Ricci, Patrizia, Urbani, Ginevra, Monti, Maria Chiara, Biagioli, Michele, Distrutti, Eleonora, Catalanotti, Bruno, Zampella, Angela, Fiorucci, Stefano

Publikováno v: Frontiers in Oncology; 3/14/2023, Vol. 13, p1-17, 17p